XML 45 R28.htm IDEA: XBRL DOCUMENT v3.5.0.2
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)
6 Months Ended
Jun. 30, 2016
Fair Value Disclosures [Abstract]  
Carrying Amount and Fair Value of Financial Instruments

The following table summarizes the carrying amount and the fair value of our financial instruments as of June 30, 2016:

 

Financial Instrument

 

Carrying

Amount

 

 

Estimated

Fair Value

 

Assets

 

 

 

 

 

 

 

 

Total investment in mortgages and loans, net

 

$

1,477,106

 

 

$

1,437,291

 

Cash and cash equivalents

 

 

66,885

 

 

 

66,885

 

Restricted cash

 

 

159,429

 

 

 

159,429

 

Derivative assets

 

 

53

 

 

 

53

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

Recourse indebtedness:

 

 

 

 

 

 

 

 

7.0% convertible senior notes

 

 

843

 

 

 

935

 

4.0% convertible senior notes

 

 

119,474

 

 

 

116,452

 

7.625% senior notes

 

 

55,450

 

 

 

50,435

 

7.125% senior notes

 

 

68,899

 

 

 

69,486

 

Senior secured notes

 

 

60,645

 

 

 

66,851

 

Junior subordinated notes, at fair value

 

 

10,789

 

 

 

10,789

 

Junior subordinated notes, at amortized cost

 

 

24,890

 

 

 

11,318

 

CMBS facilities

 

 

138,618

 

 

 

138,977

 

Non-recourse indebtedness:

 

 

 

 

 

 

 

 

Secured credit facilities

 

 

243,604

 

 

 

247,335

 

Term loans

 

 

39,559

 

 

 

40,000

 

CDO notes payable, at amortized cost

 

 

765,299

 

 

 

633,692

 

CMBS securitizations

 

 

586,977

 

 

 

585,918

 

Loans payable on real estate

 

 

865,691

 

 

 

910,275

 

Other indebtedness

 

 

24,521

 

 

 

24,796

 

Derivative liabilities

 

 

3,972

 

 

 

3,972

 

Warrants and investor SARs

 

 

29,300

 

 

 

29,300

 

 

The following table summarizes the carrying amount and the fair value of our financial instruments as of December 31, 2015:

 

Financial Instrument

 

Carrying

Amount

 

 

Estimated

Fair Value

 

Assets

 

 

 

 

 

 

 

 

Total investment in mortgages and loans, net

 

$

1,606,486

 

 

$

1,537,086

 

Cash and cash equivalents

 

 

125,886

 

 

 

125,886

 

Restricted cash

 

 

213,012

 

 

 

213,012

 

Derivative assets

 

 

206

 

 

 

206

 

Liabilities

 

 

 

 

 

 

 

 

Recourse indebtedness:

 

 

 

 

 

 

 

 

7.0% convertible senior notes

 

 

28,868

 

 

 

27,795

 

4.0% convertible senior notes

 

 

133,039

 

 

 

104,184

 

7.625% senior notes

 

 

57,952

 

 

 

46,560

 

7.125% senior notes

 

 

69,749

 

 

 

62,471

 

Senior secured notes

 

 

63,045

 

 

 

66,725

 

Junior subordinated notes, at fair value

 

 

10,504

 

 

 

10,504

 

Junior subordinated notes, at amortized cost

 

 

24,884

 

 

 

11,221

 

CMBS facilities

 

 

96,723

 

 

 

97,067

 

Non-recourse indebtedness:

 

 

 

 

 

 

 

 

Secured credit facilities

 

 

267,155

 

 

 

271,500

 

Term loans

 

 

118,418

 

 

 

120,000

 

CDO notes payable, at amortized cost

 

 

937,569

 

 

 

801,289

 

CMBS securitizations

 

 

708,510

 

 

 

709,001

 

Loans payable on real estate

 

 

811,666

 

 

 

834,816

 

Derivative liabilities

 

 

4,727

 

 

 

4,727

 

Warrants and investor SARs

 

 

26,200

 

 

 

26,200

 

 

Information of Assets and Liabilities Measured at Fair Value on Recurring Basis

The following tables summarize information about our assets and liabilities measured at fair value on a recurring basis as of June 30, 2016, and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value:

Assets:

 

Quoted Prices in

Active Markets for

Identical Assets

(Level 1) (a)

 

 

Significant Other

Observable Inputs

(Level 2) (a)

 

 

Significant

Unobservable Inputs

(Level 3) (a)

 

 

Balance as of June 30, 2016

 

Derivative assets

 

$

 

 

$

53

 

 

$

 

 

$

53

 

Total assets

 

$

 

 

$

53

 

 

$

 

 

$

53

 

 

Liabilities:

 

Quoted Prices in

Active Markets for

Identical Assets

(Level 1) (a)

 

 

Significant Other

Observable Inputs

(Level 2) (a)

 

 

Significant

Unobservable Inputs

(Level 3) (a)

 

 

Balance as of June 30, 2016

 

Junior subordinated notes, at fair value

 

$

 

 

$

 

 

$

10,789

 

 

$

10,789

 

Derivative liabilities

 

 

 

 

 

3,972

 

 

 

 

 

 

3,972

 

Warrants and investor SARs

 

 

 

 

 

 

 

 

29,300

 

 

 

29,300

 

Total liabilities

 

$

 

 

$

3,972

 

 

$

40,089

 

 

$

44,061

 

 

(a)

During the six months ended June 30, 2016, there were no transfers between Level 1 and Level 2, and there were no transfers into and/or out of Level 3.

The following tables summarize information about our assets and liabilities measured at fair value on a recurring basis as of December 31, 2015, and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value:

 

Assets:

 

Quoted Prices in

Active Markets for

Identical Assets

(Level 1) (a)

 

 

Significant Other

Observable Inputs

(Level 2) (a)

 

 

Significant

Unobservable Inputs

(Level 3) (a)

 

 

Balance as of December 31, 2015

 

Derivative assets

 

$

 

 

$

206

 

 

$

 

 

$

206

 

Total assets

 

$

 

 

$

206

 

 

$

 

 

$

206

 

 

Liabilities:

 

Quoted Prices in

Active Markets for

Identical Assets

(Level 1) (a)

 

 

Significant Other

Observable Inputs

(Level 2) (a)

 

 

Significant

Unobservable Inputs

(Level 3) (a)

 

 

Balance as of December 31, 2015

 

Junior subordinated notes, at fair value

 

$

 

 

$

 

 

$

10,504

 

 

$

10,504

 

Derivative liabilities

 

 

 

 

 

4,727

 

 

 

 

 

 

4,727

 

Warrants and investor SARs

 

 

 

 

 

 

 

 

26,200

 

 

 

26,200

 

Total liabilities

 

$

 

 

$

4,727

 

 

$

36,704

 

 

$

41,431

 

 

(a)

During the year ended December 31, 2015, there were no transfers between Level 1 and Level 2, and there were no transfers into and/or out of Level 3.

Rollforward of Level 3 Liabilities

 

Liabilities

 

Warrants and investor SARS

 

 

Junior Subordinated Notes, at Fair Value

 

 

Total

Level 3

Liabilities

 

Balance, as of December 31, 2015

 

$

26,200

 

 

$

10,504

 

 

$

36,704

 

Change in fair value of financial instruments

 

 

3,100

 

 

 

285

 

 

 

3,385

 

Purchases

 

 

 

 

 

 

 

 

 

Principal Repayments

 

 

 

 

 

 

 

 

 

Balance, as of June 30, 2016

 

$

29,300

 

 

$

10,789

 

 

$

40,089

 

 

Fair Value Hierarchy for Financial Instruments Not Fair Valued but For Which Fair Value Is Required To Be Disclosed

The following tables summarize the valuation technique and the level of the fair value hierarchy for financial instruments that are not fair valued in the accompanying consolidated balance sheets but for which fair value is required to be disclosed. The fair value of cash and cash equivalents, restricted cash, secured credit facilities, CMBS facilities, commercial mortgage facilities and other indebtedness approximates cost due to the nature of these instruments and are not included in the tables below.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Carrying Amount

as of June 30, 2016

 

 

Estimated Fair

Value as of June 30, 2016

 

 

Valuation

Technique

 

Level in Fair Value Hierarchy

Total investment in mortgages and loans, net

 

$

1,477,106

 

 

$

1,437,291

 

 

Discounted cash flows

 

Three

7.0% convertible senior notes

 

 

843

 

 

 

935

 

 

Trading price

 

One

4.0% convertible senior notes

 

 

119,474

 

 

 

116,452

 

 

Trading price

 

One

7.625% senior notes

 

 

55,450

 

 

 

50,435

 

 

Trading price

 

One

7.125% senior notes

 

 

68,899

 

 

 

69,486

 

 

Trading price

 

One

Senior secured notes

 

 

60,645

 

 

 

66,851

 

 

Discounted cash flows

 

Three

Junior subordinated notes, at amortized cost

 

 

24,890

 

 

 

11,318

 

 

Discounted cash flows

 

Three

CDO notes payable, at amortized cost

 

 

765,299

 

 

 

633,692

 

 

Discounted cash flows

 

Three

CMBS securitizations

 

 

586,977

 

 

 

585,918

 

 

Discounted cash flows

 

Three

Loans payable on real estate

 

 

865,691

 

 

 

910,275

 

 

Discounted cash flows

 

Three

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Carrying Amount

as of December 31, 2015

 

 

Estimated Fair

Value as of December 31, 2015

 

 

Valuation

Technique

 

Level in Fair Value Hierarchy

Total investment in mortgages and loans, net

 

$

1,606,486

 

 

$

1,537,086

 

 

Discounted cash flows

 

Three

7.0% convertible senior notes

 

 

28,868

 

 

 

27,795

 

 

Trading price

 

One

4.0% convertible senior notes

 

 

133,039

 

 

 

104,184

 

 

Trading price

 

One

7.625% senior notes

 

 

57,952

 

 

 

46,560

 

 

Trading price

 

One

7.125% senior notes

 

 

69,749

 

 

 

62,471

 

 

Trading price

 

One

Senior secured notes

 

 

63,045

 

 

 

66,725

 

 

Discounted cash flows

 

Three

Junior subordinated notes, at amortized cost

 

 

24,884

 

 

 

11,221

 

 

Discounted cash flows

 

Three

CDO notes payable, at amortized cost

 

 

937,569

 

 

 

801,289

 

 

Discounted cash flows

 

Three

CMBS securitization

 

 

708,510

 

 

 

709,001

 

 

Discounted cash flows

 

Three

Loans payable on real estate

 

 

811,666

 

 

 

834,816

 

 

Discounted cash flows

 

Three

 

Summary of Realized and Unrealized Gains and Losses on Assets and Liabilities

The following table summarizes realized and unrealized gains and losses on assets and liabilities for which we elected the fair value option of FASB ASC Topic 825, “Financial Instruments” and derivatives as reported in change in fair value of financial instruments in the accompanying consolidated statements of operations:

 

 

 

For the Three Months Ended June 30,

 

 

For the Six Months Ended June 30,

 

Description

 

2016

 

 

2015

 

 

2016

 

 

2015

 

Change in fair value of trading securities and

   security-related receivables

 

$

 

 

$

 

 

$

 

 

$

(173

)

Change in fair value of junior subordinated notes

 

 

(1,004

)

 

 

316

 

 

 

(285

)

 

 

236

 

Change in fair value of derivatives

 

 

(388

)

 

 

1,627

 

 

 

(2,295

)

 

 

(420

)

Change in fair value of warrants and investors SARs

 

 

(200

)

 

 

6,413

 

 

 

(3,100

)

 

 

13,203

 

Change in fair value of financial instruments

 

$

(1,592

)

 

$

8,356

 

 

$

(5,680

)

 

$

12,846